ESMO Breast Cancer is an annual congress taking place for the first time on 2-4 May 2019 in Berlin, Germany. Brought to you by ESMO, your trusted provider of specialised education in oncology.
We are delighted to inform you that the long-term follow-up results of the randomized IIBIS-II trial have been published in Lancet.
Results of a protocol-predefined secondary analysis from PANTHER trial have been published in Cancer.
ESMO Breast Cancer 2020 will take place on 7-9 May 2020 in Berlin, Germany.
A translational study evaluating the role of tumor immunogenicity in patients from GeparTrio trial has been published in Breast Cancer Research.
GBG Forschungs GmbHMartin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd